BRIEF-Blueprint Medicines Q1 Net Income USD 496 Thousand Vs. IBES Estimate USD -35.6 Million

Reuters
01 May
BRIEF-Blueprint Medicines Q1 Net Income USD 496 Thousand Vs. IBES Estimate USD -35.6 Million

May 01 (Reuters) - Blueprint Medicines Q1 product revenue USD 149.413 million.

  • Q1 basic EPS USD 0.01
  • Q1 operating expenses USD 190.499 million
  • Q1 EPS USD 0.01 vs. IBES estimate USD -0.53
  • Q1 pretax profit USD 1.285 million vs. IBES estimate USD -35.3 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10